Andrew Farquharson - 28 May 2025 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role: Director
Signature: /s/ Svai Sanford, Attorney-in-Fact for Andrew Farquharson
Issuer symbol: RANI
Transactions as of: 28 May 2025
Net transactions value: $0
Form type: 4
Filing time: 30 May 2025, 17:45:46 UTC
Previous filing: 17 Dec 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Farquharson Andrew	Director	C/O RANI THERAPEUTICS LLC, 2051 RINGWOOD AVE., SAN JOSE	/s/ Svai Sanford, Attorney-in-Fact for Andrew Farquharson	30 May 2025	0001865699

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RANI	Director Stock Option (Right to Buy)	Award	$0	+50,000		$0.000000	50,000	28 May 2025	Class A Common Stock	50,000	$0.6200	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan).

Content

The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan).